Carol Yan, MD
Otolaryngology · San Diego, CANPI 1619237260
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.3%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medtronic at 30.6% of the total. 2025 is the largest year on record at $1,567, 2.1 times the $756 reported in 2019.
Across 43 payments — averaging $81.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Aerin Medical Inc.$1K
- Stryker$567
- AstraZeneca$280
- Neurent Medical Limited$189
- Integra Lifesciences Corporation$142
- plus $251 from 4 others
What the payments were for
- Consulting fees$1,00028%
- Speaking & faculty fees$64018%
- Food & beverage$1,87253%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 10 | $1,074 |
| Aerin Medical Inc. | 2 | $1,009 |
| Stryker | 12 | $567 |
| AstraZeneca | 3 | $280 |
| Neurent Medical Limited | 7 | $189 |
| Integra Lifesciences Corporation | 2 | $142 |
| Optinose US, Inc. | 2 | $114 |
| Intersect ENT, Inc. | 3 | $74 |
| Kls-martin L.p. | 1 | $38 |
| Acclarent, Inc | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$1,000
- RHINOBUR$640
- SCOPIS ENT$121
- Acclarent Aera$117
- Inspira Air$117
- RELIEVA SPINPLUS NAV$117
- TruDi Probe$117
- Chitogel$116
- Xhance$100
How this compares
$3,512 in reported general payments places this provider in the 75th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 78 | $5,739 |
| Ipratropium Bromide | 67 | $3,388 |
| Azelastine Hcl | 43 | $808 |
| Fluticasone Propionate | 30 | $328 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $237 |
| Prednisone | 15 | $50 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $46 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in San Diego
- Brian WeeksSan Diego$924K
- Adam DecondeSan Diego$32K
- Theresa GuoSan Diego$24K
- Charles TesarSan Diego$21K
- Charles CoffeySan Diego$20K
- Erik ViirreSan Diego$17K
- Jo-Lawrence BigcasSan Diego$15K
- Randall OwRoseville$613K
- Amir MoradiVista$389K
- Keith BlackwellLos Angeles$349K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.